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Figure 1. Construction of Individual-Specific Kinetic Models of Metabolism
Incorporation of multi-omics information in the dynamic concentration balances in the form of 13C
metabolic flux data, baseline enzyme levels, metabolite concentrations as well as substrate level
regulation could enable the parameterization (left) and personalization (right) of kinetic models of
metabolism.
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Previewsdescriptions of metabolism, could pro-
vide the necessary tools in the future
for parameterizing large-scale person-
alized kinetic models for monitoring
individual health as well as suggestingpharmacological strategies compatible
with the individual genotype. This will
require careful parameterization of the
kinetic models and confirmation of the
proposed mechanisms of action.Cell Systems 1REFERENCES
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Two recent papers in Cell interpret lists of cancer genomic alterations in terms of how mutations rewire
interactome networks.The human genome project, conventional
positional cloning efforts, and genome-
wide association studies (GWAS), as
well as exome sequencing and full
genome sequencing of large numbers of
tumors, have identified a nearly complete
list of candidate human cancer genes. But
how these genomic variants, sometimes
referred to as the cancer ‘‘variome,’’ lead
to tumorigenesis remains obscure. Toaddress this issue, work by Creixell et al.
published in Cell describe new ap-
proaches for harnessing orthogonal data
to functionally annotate a subset of the
cancer variome (Creixell et al., 2015a;
Creixell et al., 2015b). More importantly,
these two papers put the cancer variome
in the context of signaling networks to
understand how individual cancer varia-
tions initiate network perturbations. Thesetools promise to advance our understand-
ing of mechanisms of tumorigenesis,
which in turn may provide leads for the
development of novel effective therapeu-
tic interventions.
Although lists of cancer mutations
are critical to understand the genetic
architecture of the cancer genome, it is
increasingly appreciated that complex
molecular networks and systems formed, October 28, 2015 ª2015 Elsevier Inc. 251
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Previewsby large numbers of interacting genes
and gene products operate within and
between human cells (Vidal et al., 2011).
Systems and ‘‘interactome’’ networks
are thought to exhibit emergent proper-
ties that cannot be understood by study-
ing a single gene or gene product in
isolation, and perturbations of such
properties of complex cellular networks
are likely to underlie most genotype-
phenotype relationships, including those
related to the pathogenesis of cancer.
There is an urgent need for concepts,
technologies, and a new generation of
systematic datasets to functionalize and
contextualize the cancer variome into
predictive models of perturbed interac-
tome networks.
Cancer research has made consider-
able progress in the last four decades
with crucial conceptual shifts occurring
along the way (Weinberg, 2014). The dis-
covery of human oncogenes starting
with RAS in the early 1980s followed a
few years later by tumor suppressor
genes such as RB firmly established can-
cer as a genetic disease. Another concep-
tual shift originated from the observation
that the products of oncogenes and tumor
suppressor genes interact both physically
and functionally in the context of so-
called cancer pathways. With the cancer
variome in hand, it is now becoming
possible to characterize all interaction
perturbations in all cancer pathways in
any cancer cell type and understand
how interactome networks are globally re-
wired to lead to tumorigenesis.
Given the enormous complexity of such
a task, it would make sense to start from a
class of well-defined interactions such as
those involving kinases and their sub-
strates. A challenging goal would then
be to annotate cancer alleles occurring
in kinases and/or their substrates from
the point-of-view of how such mutations
affect kinase specificity, and this is
exactly what the two papers by Creixell
et al. have initiated.
In the first paper, a computational
method referred to as ‘‘KINspect’’ is
described to understand kinase-sub-
strate interaction specificity at the level
of individual protein residues. The authors
noticed that when comparing the
sequence similarity of whole kinase do-
mains versus substrate motifs, no strong
linear correlation could be found. They hy-
pothesized that the lack of correlation252 Cell Systems 1, October 28, 2015 ª2015might be due to the fact that not every res-
idue in the kinase domain is responsible
for substrate specificity. It turns out that
the information is diluted when using
whole domain sequences. To identify
the critical positions within the domain,
termed the determinants of specificity
(DoS), the authors used a mask to weight
each position to quantify the contribution
of each residue to the substrate speci-
ficity, so that highly weighted positions
could be regarded as determinants of
specificity. To obtain the best mask with
optimum predictive power of substrate
specificity, a heuristic genetic algorithm
was employed, which included a com-
parison to values determined experi-
mentally by positional scanning peptide
library (PSPL) screens. By using the
specificity mask, the authors reported
that the correlation could be enhanced
by about 40%.
Notably, KINspect does not involve any
artificial parameters, which allows the
methodology to be potentially transfer-
rable to other domains or other biological
questions. Although no mechanism of
how these positions determine kinase-
substrate specificity was unveiled from
this work, the pinpointed positions can
serve as guideposts for follow-up studies,
for example structure-based mechanistic
studies or mutagenesis studies.
In the second paper, the authors
integrated KINspect and other methods
into a comprehensive platform referred
to as ReKINect, by which a subset of
the cancer variome can be annotated
and categorized. These mutations are
defined as network-attacking mutations
or ‘‘NAMs’’ because they are thought to
potentially perturb kinome signaling net-
works. Network-attacking mutations
were separately classified into six basic
categories, including genesis/extinction
of phosphorylation sites, downstream/
upstream network rewiring, and kinase
activation/inactivation, using six different
computational approaches combining
different information sources. A number
of interesting observations were derived
from this analysis. For example, exome
sequencing and proteomic data were
combined to predict whether muta-
tions can create or destroy phosphoryla-
tion sites. Determinants of specificity
discovered by KINspect were used to
identify kinase downstream rewiring
mutations. Catalytically essential residuesElsevier Inc.that mediate ATP binding, Mg2+ coordina-
tion, or phospho-transfer were used to
predict kinase inactivation mutations.
Although ReKINect was useful for
analyzing a relatively small fraction of
somatic cancer mutations, these two
studies (Creixell et al., 2015a; Creixell
et al., 2015b) undertook an integrative
network approach that represents a
huge leap forward toward the interpreta-
tion of heterogeneous cancer mutations.
This kind of multi-level integration and
processing of network information will
be crucial to interrogate how cancer
variants affect interactome networks
(Figure 1). Indeed, the functional conse-
quences of most mutations remain
unknown. What mutations are actually
disease drivers? How do they increase
the risk of disease? What underlies phe-
nomena such as incomplete penetrance?
These questions are still daunting chal-
lenges in cancer research. Answering
them will require the development of
both additional computational methods
and novel high-throughput experimental
strategies to functionalize and contextu-
alize large numbers of putative cancer
related mutations.
Such efforts have already been initiated
in the context of addressing the extent to
which human Mendelian disease muta-
tions tend to lead to ‘‘node removal’’ or
more subtle ‘‘edgetic perturbations’’ in
the context of global interactome network
models (in the lexicon of network biology,
genes or gene products, and interactions
between them are referred to as nodes
and edges, respectively, and thus muta-
tions that affect one or a few edges while
leaving all others unperturbed have been
named ‘‘edgetic alleles’’) (Zhong et al.,
2009). A recent systematic characteriza-
tion of thousands of Mendelian muta-
tions has unraveled widespread specific
macromolecular interaction perturba-
tions, both at the level of binary protein-
protein interactions and transcription
factor binding interactions, across a large
number of disease genes (Sahni et al.,
2015). Although many Mendelian disease
alleles can impact protein folding and/or
stability, more than half appear edgetic
in terms of biophysical interactions. This
is in marked contrast to non-disease nat-
ural variants, which tend to retain most in-
teractionsmediated by the corresponding
wild-type gene products (Sahni et al.,
2015).
Figure 1. Edgetic Rewiring in Cancer Networks
One of the bottlenecks in cancer research is to understand how cancer variants result in tumorigenesis.
One promising strategy to address this is to use global models of how edgetic mutations, which affect
interactions between genes or gene products, rewire networks. Different colored boxes indicate distinct
network-based profiles that are discussed in this Preview.
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PreviewsIn addition to the kinase/substrate re-
wiring reported by Creixell et al., other
approaches have been described to char-
acterize the cancer variome from the
point-of-view of global rewiring of cancer
networks. For example, Wang et al.
(2012) analyzed disease-related muta-
tions in the context of a protein 3D
structure network and found that in-
frame disease mutations are significantly
enriched on interaction interfaces and
depleted outside domains. Kiel and
Serrano (2014) took a step further to use
structure-based energy calculations to
estimate the effect of mutations on partic-
ular edges. Yang et al. (2015) and Miller
et al. (2015) demonstrated how cancer
mutations in distinct domains are likely
to mediate different edgetic perturbations
resulting in different tumor phenotypesand identified where the mutation hot-
spots reside in domains. Finally, Leiser-
son et al. (2015) developed a computa-
tional framework based on a directed
heat diffusion model to identify subnet-
works significantly mutated in cancer.
Together, this body of work suggests
that the bottleneck represented by the
tens of thousands of uncharacterized
cancer genomic alterations might be pro-
gressively cracked open by considering
the variome in the context of network
and systems models (Figure 1).
In this context, a ‘‘functional cancer
variome project’’, utilizing a comprehen-
sive collection of wild-type and mutant
alleles, is urgently needed to empirically
assess the effects of cancer mutations at
an unprecedented scale on physical
interactions, biochemical activities, andCell Systems 1cellular assays. Examples would include
but would not be limited to transcription
factor binding, kinase and phosphatase
assays, ubiquitination and de-ubiquitina-
tion assays, or acetyltransferase and de-
acetylase assays. Powerful computational
prediction tools such as those described
by Creixel et al. coupled with novel vari-
ome-wide experimental approaches will
be necessary to determine which edges
of interactome networks are perturbed
in cancer and what the consequences
of such perturbations might be in the
context of global edgetic rewiring in can-
cer networks.ACKNOWLEDGMENTS
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